The 20 Best Retinitis Pigmentosa Doctors Near Me in New York, US

. Dr. Travor is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. His clinical expertise encompasses Usher Syndrome, Retinitis Pigmentosa, and Retinopathy Pigmentary Mental Retardation.

Paul Hahn is an Ophthalmologist practicing medicine in Nanuet, New York. Dr. Hahn is rated as a Distinguished provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal. Dr. Hahn is board certified in American Board Of Ophthalmology.

Scott E. Brodie, MD, Ph.D., is a Professor of Clinical Ophthalmology and Attending Ophthalmologist in the Department of Ophthalmology. He is an internationally known clinician-scientist, and a leader in the use of electrophysiologic techniques for diagnosing of visual impairments in children and adults.Dr. Brodie is a graduate of the combined MD-PhD program at Weill-Cornell Medical College and The Rockefeller University in New York. He completed his PhD in retinal physiology in the laboratory of Nobel Laureate H. K. Hartline, under the supervision of Dr. Floyd Ratliff and Prof. Bruce Knight. He completed a medical internship and residency training in ophthalmology at The New York Hospital, and subsequently received fellowship training in medical retinal disorders and clinical electrophysiology of vision at New York University and Bellevue Hospital under the supervision of Dr. Ronald Carr, with support as a John Kluge Fellow of the Retinitis Pigmentosa Foundation.He is a fellow of the American Academy of Ophthalmology, and a fellow of the Association for Research in Vision and Ophthalmology. He is a member of the International Society for Clinical Electrophysiology of Vision, the International Society for Genetic Eye Disease, and the Ophthalmic Genetics Study Club. Dr. Brodie has been honored with the Senior Achievement Award of the American Academy of Ophthalmology, as well as the Academy's Secretariat Award for Education.Dr. Brodie’s research centers on improving methodologies for electrophysiologic testing, and descriptions of novel findings in patients with inherited and metabolic retinal disorders. He has been a key member of the teams which have introduced important new therapies, including enzyme-replacement therapy for Fabry disease, and intra-arterial chemotherapy for retinoblastoma, which has increased the rate of salvage of diseased eyes in the most severely affected patients from 20% to over 90%.Dr. Brodie has published extensively on electrophysiology and retinal disorders. He has a particular interest in clinical optics, and has served as Chair of the Editorial committee for the American Academy of Ophthalmology’s Basic and Clinical Science Course on Clinical Optics for the past ten years. In his spare time, he enjoys reading mathematics, and playing the oboe in local orchestras and chamber groups. Dr. Brodie is rated as a Distinguished provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Retinitis Pigmentosa, Cone-Rod Dystrophy, Retinopathy Pigmentary Mental Retardation, and Vitrectomy. Dr. Brodie is currently accepting new patients.

"Stephen H. Tsang, M.D, Ph.D. is an acclaimed clinical geneticist in the care of individuals with retinal degenerations. He has been culturing stem cells since 1992 and created the first mouse model for a recessive form of retinitis pigmentosa (RP) by applying genome engineering to stem cell technology in 1995. He successfully treated preclinical models of Pde6a, Pde6b, Mfrp, Rho, Cngb1 and autosomal recessive bestrophin retinopathies.He has expertise in designing and testing genome engineering strategies in pre-clinical models, developing patient-specific knock-in models, generating of patient cell lines and providing care to patients with a precision medicine approach. He is also leading efforts in FDA trials for gene therapies, including PDE6A, RAB geranylgeranyl transferase, RPGR, CNGB3, CNGA3 and ABCA4 retinopathies. He wrote 3 books: “Precision Medicine, CRISPR, and Genome Engineering: Moving from Association to Biology and Therapeutics"" and “Stem Cell Biology and Regenerative Medicine in Ophthalmology”, Springer Press, NY; and “CRISPR Genome Surgery in Stem Cells and Disease Tissues”, Elsevier Inc. He is an elected member of several honorary societies including the American Society for Clinical Investigation, Alcon Research Institute and American Ophthalmological Society. He is consistently named to various NIH study sections (DPVS standing member 2014-8 and PED2 2022-6) and other review committees; Alcon Research Institute Grant Review Committee (2022-27), Scientific Advisory Panel - Research to Prevent Blindness (RPB, 2019-29), Chair of American Ophthalmological Society Thesis Review Committee (2022-2023). Many of his publications are in widely-read general interest journals such as Science, NEJM, Lancet, Cell Stem Cell, Nature Genetics, and Journal of Clinical Investigation, which attests to the broad impact that his work has had.Dr. Tsang received a resident teaching award in 2008 and was the Columbia Ophthalmology Basic Science Course Director (2006-2018). Dr. Tsang graduated from Johns Hopkins University, where he began his medical genetics training under the tutelage of Professor Victor A. McKusick. He received his M.D. and Ph.D. degrees from the NIH-National Institute of General Medical Sciences Medical Scientist Training Program (MSTP) at Columbia University. Dr. Tsang then completed his residency at Jules Stein Eye Institute/UCLA, followed by studies with Professors Alan C. Bird and Graham E. Holder on improving the care of individuals with macular degenerations.". Dr. Tsang is rated as a Distinguished provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Leber Congenital Amaurosis, Sorsby Fundus Dystrophy, Stargardt Macular Degeneration, and Usher Syndrome. Dr. Tsang is board certified in Ophthalmology. Dr. Tsang is currently accepting new patients.

Eric Shakin is an Ophthalmologist practicing medicine in Westbury, New York. Dr. Shakin is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Vitrectomy. Dr. Shakin is board certified in American Board Of Ophthalmology.

Dr. Zagelbaum is a Diplomate of the American Board of Ophthalmology (board certified) and a Fellow of the American College of Ophthalmology (F.A.A.O.) and the American College of Surgeons (F.A.C.S.). He has written textbooks in ophthalmology, as well as book chapters and peer reviewed articles. He is currently co-editing the 3rd edition of the textbook Ophthalmic Surgical Procedures.His main interests include eye trauma and sports. He is the ophthalmology consultant to The National Football League (NFL) and The Boxing/Mixed Martial Arts Commission. He has been the team ophthalmologist for the New York Jets, New York Mets, New York Islanders, and has worked with Major League Baseball (MLB) and the National Basketball Association (NBA). Dr. Zagelbaum is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Optic Nerve Atrophy, Optic Atrophy Type 1, Glaucoma, and Eyelid Bump. Dr. Zagelbaum is board certified in American Board Of Ophthalmology.

Richard Rosen is an Ophthalmologist practicing medicine in New York, New York. Dr. Rosen is rated as a Distinguished provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Vitrectomy.

Larry Koreen is an Ophthalmologist practicing medicine in Newburgh, New York. Dr. Koreen is rated as a Distinguished provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, Retinal Artery Occlusion, and Vitrectomy.

Howard Charles is an Ophthalmologist practicing medicine in Mount Kisco, New York. Dr. Charles is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, and Diabetic Retinopathy. Dr. Charles is board certified in American Board Of Ophthalmology.

Sherry Solomon is an Ophthalmologist practicing medicine in Scarsdale, New York. Dr. Solomon is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Retinitis Pigmentosa, X-Linked Retinitis Pigmentosa (XLRP), Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).

Golnaz Moazami is an Ophthalmologist practicing medicine in New York, New York. Dr. Moazami is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Optic Nerve Atrophy, Optic Atrophy Type 1, Ocular Hypertension (OHT), and Fourth Cranial Nerve Palsy. Dr. Moazami is board certified in American Board Of Ophthalmology.

David Poon is an Ophthalmologist practicing medicine in Rockville Centre, New York. Dr. Poon is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Central Serous Chorioretinopathy, and Retinal Vein Occlusion. Dr. Poon is board certified in American Board Of Ophthalmology.

Yu Hyon Kim, MD, is an attending physician, Retina and Assistant Professor, Ophthalmology & Visual Sciences at Montefiore Einstein. His clinical focus is in all aspects of vitreoretinal diseases evaluation, treatment and surgery, with a special interest in retinovascular disease, diabetes, macular degeneration, sickle cell and vascular occlusions. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Retinal Artery Occlusion, Retinal Detachment, and Retinal Vein Occlusion.

Philip Ferrone is an Ophthalmologist practicing medicine in Elmhurst, New York. Dr. Ferrone is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Coats Disease, and Vitrectomy. Dr. Ferrone is board certified in American Board Of Ophthalmology.

Henry Oksman is an Ophthalmologist practicing medicine in White Plains, New York. Dr. Oksman is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Blepharitis, Interstitial Keratitis, Glaucoma, and Retinitis Pigmentosa.

David C. Ritterband MD, FACS is a Professor of Ophthalmology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Prior to joining Manhattan Eye, Ear and Throat Hospital (MEETH)/Northwell Eye Institute, he was a Professor of Ophthalmology at the Icahn School of Medicine at Mt Sinai and System Director of the Refractive Surgery Service for the Mount Sinai Health System. At MEETH he has assumed leadership of the Refractive Surgery division and the Laser Vision Correction Center and sees patients at the Manhattan Eye, Ear and Throat Hospital on 64th Street. Dr. Ritterband is a graduate of Duke University and received his medical degree at New York Medical College where he was elected to Alpha Omega Alpha, the national medical honor society. He completed his Ophthalmology Residency at New York Medical College where he was elected Chief Resident. He completed his Corneal and External disease and Refractive Surgery Fellowship at the University of Pittsburgh School of Medicine Eye and Ear Institute. He is a fellow of the American Academy of Ophthalmology and the American College of Surgeons. He is a past president of the Ocular Microbiology and Immunology Group and a long time Medical Board member of the Eye Bank for Sight Restoration in New York City, the world's first Eye Bank. In addition to maintaining a busy tertiary-care referral practice in New York City, Dr. Ritterband is a nationally recognized physician, scientist, and surgeon. He has published over 250 medical and scientific papers, book chapters, monographs, and research abstracts. He has lectured widely in the United States on cornea, cataract, and refractive surgery topics. His clinical and research interests include cornea transplantation, cataract surgery, ocular drug development, laser refractive surgery, and ocular infections. A committed teacher and mentor, he has trained over 50 clinical cornea fellows first at the highly regarded AUPO certified corneal fellowship program at the New York Eye and Ear Infirmary and continuing with the current AUPO corneal fellowship program at Manhattan Eye, Ear and Throat Hospital. Dr. Ritterband has received numerous awards including an Honor Award from the American Academy of Ophthalmology and has been named multiple times to New York Magazine's Best Doctors, Castle Connolly's Top Doctors, and the NY Times Magazine's Super Doctors. In addition, while at the New York Eye and Ear Infirmary he received 6 Resident Outstanding Teaching and Dedicated Service Awards. Dr. Ritterband is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Cataract, Endophthalmitis, Interstitial Keratitis, Corneal Transplant, and Trabeculectomy. Dr. Ritterband is board certified in American Board Of Ophthalmology.

Saadia Rashid is an Ophthalmologist practicing medicine in Bronx, New York. Dr. Rashid is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Diabetic Retinopathy, Retinal Detachment, Age-Related Macular Degeneration (ARMD), and Late-Onset Retinal Degeneration.

George Tung is an Ophthalmologist practicing medicine in Bellmore, New York. Dr. Tung is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Subconjunctival Hemorrhage, Dry Eye Syndrome, Eyelid Bump, and Chalazion. Dr. Tung is board certified in American Board Of Ophthalmology.

Dr. Albert Li is a board-certified, fellowship-trained vitreoretinal surgeon at Vitreoretinal Consultants of New York, a member of the Northwell Health Eye Institute. He speaks English, Mandarin Chinese and Spanish.Dr. Li specializes in diseases and surgery of the vitreous and retina, including diabetic retinopathy, age-related macular degeneration, retinal vascular occlusions, retinal detachments, macular puckers, macular holes, and cataract complications. Dr. Li is dedicated to providing compassionate care to all of his patients, employing the latest technology and applying the most up-to-date medical research in order to meet the specific needs of each patient he sees.Dr. Li graduated magna cum laude with highest honors in Chemical and Physical Biology from Harvard College. He was awarded the Thomas Temple Hoopes Prize for his undergraduate research thesis at Harvard College and inducted into The Phi Beta Kappa Society. He earned his medical degree from New York University School of Medicine and obtained his ophthalmology residency training at Hofstra Northwell School of Medicine at North Shore University Hospital and Long Island Jewish Medical Center, serving as chief resident in his final year. He then completed his vitreoretinal fellowship at Barnes-Jewish Hospital/Washington University School of Medicine in St. Louis, where he also held an academic appointment as an Instructor in Ophthalmology.Dr. Li is board certified by the American Board of Ophthalmology and a member of the American Society of Retina Specialists and the American Academy of Ophthalmology. He is currently a Clinical Assistant Professor of Ophthalmology at Zucker School of Medicine at Hofstra/Northwell, and previously served as Assistant Professor of Ophthalmology at University of Maryland School of Medicine, where he was honored as Faculty of the Year for excellence in resident teaching. Dr. Li has authored many peer-reviewed articles in the medical literature and regularly presents his clinical research at national and international ophthalmology meetings. He continues to be engaged in clinical research in retinal diseases as well as the education and training of medical students and residents in ophthalmology. Dr. Li is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Retinal Artery Occlusion, Diabetic Retinopathy, Late-Onset Retinal Degeneration, Retinal Detachment, and Vitrectomy.

David Rhee is an Ophthalmologist practicing medicine in Commack, New York. Dr. Rhee is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Detachment, and Retinal Vein Occlusion. Dr. Rhee is board certified in American Board Of Ophthalmology.